National Health Investors (NHI) Reports In-Line Q4 FFO
Tweet
Share
E-mailGet Alerts NHI Hot Sheet
Price: $70.19 --0%
Financial Fact:
Total operating expenses: 29.78M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Total operating expenses: 29.78M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
National Health Investors (NYSE: NHI) reported Q4 FFO of $1.17, in-line with the analyst estimate of $1.17.
GUIDANCE:
National Health Investors sees FY2016 FFO of $4.82-$4.88, versus the consensus of $4.90.
For earnings history and earnings-related data on National Health Investors (NHI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
- Braze, Inc. (BRZE) Tops Q2 EPS by 4c; offers guidance
- 1-800-FLOWERS.Com (FLWS) Misses Q4 EPS by 10c, Misses on Revenue; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
